At the University of Melbourne, scientists are learning to watch life's most dangerous processes unfold at the scale of individual atoms — not by isolating molecules from their world, but by observing them within it. Using cryo-electron tomography, a technique that preserves biological matter in near-absolute cold, researchers are glimpsing how pathogens invade, how bacteria resist our medicines, and how proteins misfold into the seeds of neurodegeneration. It is a shift not merely in resolution, but in philosophy: from studying life extracted from context to witnessing it as it actually lives
Cryo-electron microscopy reveals pathogen mechanisms at molecular resolution
Like watching a molecular movie inside an intact cell
Mark
When you say you can see individual amino acids inside a living cell, what does that actually look like on a screen?
Mimi
It's not like a photograph. It's a reconstruction built from thousands of images, each one a thin slice through the frozen cell. The computer stitches them together into a 3D map. You see electron density—darker and lighter regions that correspond to where atoms are clustered. A trained eye reads that density the way a radiologist reads an X-ray.
Mark
And the freezing—does that kill the cell, or does it preserve it exactly as it was?
Mimi
It preserves it in a snapshot. The extreme cold stops all molecular motion instantly, so proteins and pathogens are locked in whatever configuration they were in at that moment. It's not alive anymore, but it's also not degraded or chemically altered. You're seeing the real architecture.
Mark
So if you're watching a pathogen inject toxin, you're not actually watching it happen in real time—you're seeing frozen frames of the process?
Mimi
Exactly. But because you can prepare samples at different stages of infection, you can reconstruct the sequence. It's like having a series of photographs of a diver in mid-air. You can infer the motion even though each image is static.
Mark
Why does antibiotic resistance matter so much here? Bacteria have been resisting drugs for decades.
Mimi
Because we've been treating it as a black box. We see that a drug doesn't work, but we don't see why at the molecular level. CryoET lets us watch how the bacterial protein actually changes shape or how the drug fails to bind. Once you see the mechanism, you can design a new drug that works around it.
Mark
And the Alzheimer's angle—how does seeing protein fibrils early change anything?
Mimi
Prevention instead of management. Right now we diagnose Alzheimer's after massive damage is done. If we can see the fibrils forming at the molecular level, we might catch them before they aggregate, before they cause disease. That's the promise.
Il Polso
- At 3–4 nanometer resolution — and near-atomic clarity when images are combined — cryoET reveals biological structures that were effectively invisible to science just years ago.
- The stakes are acute: antibiotic resistance is projected to kill more people than cancer by 2050, and diseases like Alzheimer's continue to outpace the therapies designed to treat them.
- By freezing samples to nearly minus 190 degrees Celsius, researchers preserve cells in their natural, hydrated state — capturing pathogens mid-attack rather than reconstructing them after the fact.
- The Melbourne team is now mapping the precise moments when bacteria inject toxins and viruses breach human cells, identifying molecular chokepoints where new drugs could intervene.
- The platform is expanding outward — from infectious disease into neurodegenerative research, evolutionary biology, and fundamental cell mechanics — with imagination, not technology, as the binding constraint.
At the University of Melbourne, scientists are learning to watch life's most dangerous processes unfold at the scale of individual atoms — not by isolating molecules from their world, but by observing them within it. Using cryo-electron tomography, a technique that preserves biological matter in near-absolute cold, researchers are glimpsing how pathogens invade, how bacteria resist our medicines, and how proteins misfold into the seeds of neurodegeneration. It is a shift not merely in resolution, but in philosophy: from studying life extracted from context to witnessing it as it actually lives.
Inside a University of Melbourne laboratory, researchers are watching pathogens at work at the scale of individual atoms. Associate Professor Debnath Ghosal and his team have built their work around cryo-electron tomography — cryoET — a technique that freezes biological samples to nearly minus 190 degrees Celsius and preserves them in their natural, hydrated state, allowing scientists to see structures at 3 to 4 nanometer resolution, approaching individual amino acids and water molecules when multiple images are combined.
The technology gained public attention during the COVID-19 pandemic, when electron cryo-microscopy helped decode the coronavirus and accelerate vaccine design. But cryoET goes further. Where earlier cryo-EM methods required scientists to purify proteins and viruses in isolation — stripping away the cellular environment where they actually function — cryoET observes molecular structures inside intact cells. As Ghosal describes it, researchers are watching a molecular movie unfold in real time, catching the precise moments when pathogens inject toxins and identifying where a therapeutic intervention might stop the attack.
The implications reach well beyond infectious disease. Antibiotic resistance, projected to surpass cancer as a cause of death by 2050, may yield new vulnerabilities when examined at this resolution. Neurodegenerative diseases like Alzheimer's and Parkinson's, where protein misfolding begins long before symptoms appear, could become targets for earlier, preventative approaches.
Ghosal places the Melbourne institute at the forefront of in situ structural biology — the study of life in its original context rather than in artificial isolation. As the technology matures, its reach could extend across drug development, evolutionary research, and fundamental cell biology. The limiting factor, he suggests, is no longer what scientists can see. It is what they can imagine doing with what they now see.
Inside a laboratory at the University of Melbourne, researchers are watching pathogens at work—not through a conventional microscope, but through a technology that freezes biological samples to nearly 200 degrees below zero and reveals their secrets at the scale of individual atoms. Associate Professor Debnath Ghosal and his team have built a platform around cryo-electron tomography, or cryoET, a technique that is reshaping how scientists understand infection, disease, and the fundamental mechanics of cells themselves.
The technology emerged into public consciousness during the COVID-19 pandemic, when electron cryo-microscopy helped researchers decode how the coronavirus functioned and accelerated vaccine design. But cryoET represents a leap beyond that earlier application. Traditional light microscopes can distinguish objects separated by about 200 nanometers—roughly the width of a bacterium. CryoET pushes resolution down to 3 or 4 nanometers, and when researchers average multiple images together, they can approach near-atomic resolution, seeing individual amino acids and water molecules. The method works by operating at temperatures between minus 180 and minus 190 degrees Celsius, cold enough to preserve biological structures in their natural, hydrated state.
What makes cryoET fundamentally different from its cousin, cryo-EM single particle analysis, is context. The older technique requires scientists to purify proteins and viruses in the laboratory before studying them—a process that strips away the cellular environment where these molecules actually function. CryoET, by contrast, visualizes molecular structures inside intact cells, revealing how pathogens behave in their native habitat. "It's like watching a molecular movie inside an intact cell," Ghosal explains. Researchers can now observe the precise mechanisms by which pathogens inject toxins into human cells, catching the infection process as it unfolds and identifying points where therapeutic intervention might block the attack.
The implications extend far beyond infectious disease. Antibiotic resistance stands as one of the most pressing public health challenges of the coming decades—projections suggest it will cause more deaths than cancer by 2050. CryoET offers a window into how bacteria resist drugs at the molecular level, potentially opening pathways to new treatments. The same technology could illuminate neurodegenerative diseases like Alzheimer's and Parkinson's, where early visualization of protein fibrils might enable preventative approaches rather than waiting for symptoms to emerge.
Ghosal positions the Melbourne institute at the global forefront of what researchers call in situ structural biology—the study of biological structures in their original context. As imaging capabilities continue to improve, the applications could sprawl across the entire landscape of life sciences: fundamental cell biology, drug development, evolutionary research, disease mechanisms. The limitation, he suggests, is not technological but imaginative. What researchers can now see, they can now target. And what they can target, they can potentially treat.
Citazioni salienti
Everything we thought we knew about how cells function is being dramatically refined. We can actually see the mechanisms that pathogens use to inject toxins into human cells.— Associate Professor Debnath Ghosal
From fundamental cell biology to disease mechanisms, drug development, and even evolutionary biology—this platform has the potential to transform our understanding across the entire spectrum of life sciences.— Associate Professor Debnath Ghosal
Vuoi la storia completa?
Leggi l'originale su Doherty Institute ↗
Education